Health Care & Life Sciences » Pharmaceuticals | Daewoong Pharmaceutical Co. Ltd.

Daewoong Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Daewoong Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
61,511
0.53%
-35,591
0%
12/31/2017
Vanguard Total International Stock Index Fund
60,868
0.53%
0
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
48,002
0.41%
0
0.02%
09/05/2018
DFA Emerging Markets Small Cap Series
37,952
0.33%
0
0.1%
01/31/2018
Baring Korea Trust
27,764
0.24%
5,012
3.31%
10/31/2017
Vanguard Developed Markets Index Fund
24,539
0.21%
0
0%
07/31/2018
Mirae Asset TIGER 200
17,439
0.15%
1,328
0.11%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
16,355
0.14%
0
0.01%
04/30/2018
Vanguard FTSE All World (ex-US) Small Cap
10,418
0.09%
0
0.03%
07/31/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
9,545
0.08%
0
0.02%
09/05/2018

About Daewoong Pharmaceutical Co.

View Profile
Address
244 Galmachi-ro
Seongnam GY 13211
Korea, Republic Of
Employees -
Website http://www.daewoong.co.kr
Updated 07/08/2019
Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include general drugs, prescription drugs, health foods, medical devices, quasi drugs, and cosmetics. The company was founded on October 2, 2002 and is headquartered in Seongnam, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.